Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session

Published 09/12/2022, 18:48
Updated 09/12/2022, 20:10
© Reuters.  Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session

Benzinga - Gainers

  • Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
  • ClearOne, Inc. (NASDAQ: CLRO) gained 85% to $1.51 after the company and Shure Incorporated announced they reached a global settlement of all pending legal disputes.
  • Rockley Photonics Holdings Limited (NYSE: RKLY) rose 48.3% to $0.4218 after jumping 18% on Thursday. Rockley Photonics, last month, reported worse-than-expected Q3 sales results and issued 2022 revenue guidance below estimates.
  • Marin Software Incorporated (NASDAQ: MRIN) shares climbed 34.5% to $1.52. Marin Software joined the Walmart (NYSE:WMT) Platform Partner program as an API partner.
  • UpHealth, Inc. (NYSE: UPH) shares climbed 30.6% to $3.06. Healthcare transformation expert Timothy Wilde joined UpHealth as Chief Technology Officer.
  • China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 29.4% to $2.7953.
  • Hello Group Inc. (NASDAQ: MOMO) jumped 29% to $8.77. Morgan Stanley (NYSE:MS) upgraded Hello Group from Equal-Weight to Overweight and raised the price target from $5 to $9.
  • Arcellx, Inc. (NASDAQ: ACLX) gained 27.8% to $27.71. Kite, a Gilead Sciences Inc (NASDAQ:GILD) company, announced a global strategic collaboration to co-develop and co-commercialize Arcellx’s lead late-stage product candidate, CART-ddBCMA, for relapsed or refractory multiple myeloma. Arcellx also announced interim CART-ddBCMA Phase 1 results (October 31, 2022 cutoff date), demonstrating deep and durable responses.
  • Baudax Bio, Inc. (NASDAQ: BXRX) shares gained 23% to $5.01 after the company announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery.
  • Daktronics, Inc. (NASDAQ: DAKT) jumped 23% to $2.1518. Daktronics delayed its earnings release to address the determination that there is 'substantial doubt' over its ability to continue as a going concern.
  • Acer Therapeutics Inc. (NASDAQ: ACER) gained 21% to $1.90. Acer Therapeutics recently reported a $1.5 million private placement.
  • HUYA Inc. (NYSE: HUYA) rose 20.6% to $3.39.
  • NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares rose 20.4% to $2.0907 after gaining 25% on Thursday. Ladenburg Thalmann recently initiated coverage on NeuroBo Pharmaceuticals with a Buy rating and announced a price target of $6.
  • Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 19.2% to $1.1799.
  • SpringBig Holdings, Inc. (NASDAQ: SBIG) jumped 18.4% to $0.7578.
  • Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) rose 18.3% to $0.1341. Powerbridge Technologies, last month, announced the strategic acquisition of DTI Group.
  • Domo, Inc. (NASDAQ: DOMO) gained 17.7% to $17.53 following better-than-expected Q3 results.
  • Armata Pharmaceuticals, Inc. (NYSE: ARMP) jumped 17.7% to $2.26.
  • Phreesia, Inc. (NYSE: PHR) rose 16.4% to $31.08 after the company posted upbeat Q3 sales and raised FY23 revenue guidance.
  • Braemar Hotels & Resorts Inc. (NYSE: BHR) gained 16.2% to $4.01. Braemar Hotels & Resorts announced an increase in quarterly dividend from $0.01 per share to $0.05 per share and authorized $25 million for share repurchases.
  • DocuSign, Inc. (NASDAQ: DOCU) rose 15.8% to $50.68 after the company reported better-than-expected financial results for its third quarter and issued strong guidance. Piper Sandler upgraded the stock from Underweight to Neutral and lowered the price target from $54 to $50.
  • iClick Interactive Asia Group Limited (NASDAQ: ICLK) gained 14.9% to $4.0901.
  • Johnson Outdoors Inc. (NASDAQ: JOUT) jumped 12.8% to $64.83 following better-than-expected quarterly results.
  • Ikena Oncology, Inc. (NASDAQ: IKNA) gained 12.7% to $3.09.
  • Harpoon Therapeutics, Inc. (NASDAQ: HARP) jumped 11.8% to $1.07.
  • Ecoark Holdings, Inc. (NASDAQ: ZEST) gained 9.3% to $0.59.
  • WaveDancer, Inc. (NASDAQ: WAVD) jumped 9.3% to $0.66.
  • Korea Electric Power Corporation (NYSE: KEP) rose 8.9% to $8.07.
  • National Beverage Corp. (NASDAQ: FIZZ) gained 8% to $52.33 following Q2 results.
  • China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) rose 8% to $0.5199 after dropping 13% on Thursday.
  • Broadcom (NASDAQ:AVGO) Inc. (NASDAQ: AVGO) gained 3.7% to $550.93 as the company reported better-than-expected results for its fourth quarter and issued strong sales forecast for the current quarter. Broadcom also raised the quarterly dividend by 12% to $4.60 per share.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Losers

  • Getaround Inc. (NYSE: GETR) shares tumbled 64.8% to $3.10. Getaround reported closing of business combination with InterPrivate II Acquisition Corp.
  • Grom Social Enterprises, Inc. (NASDAQ: GROM) dipped 58% to $1.6195. Grom Social Enterprises priced $5 million public offering of 1,415,682 units at a price of $2.89 per unit
  • Autolus Therapeutics plc (NASDAQ: AUTL) fell 34.9% to $1.9475 after the company announced pricing of a public offering. The company’s Phase 2 pivotal FELIX trial of obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) adult Acute Lymphoblastic Leukemia (ALL) has met its primary endpoint of Overall Remission Rate (ORR).
  • Meta Materials Inc. (NASDAQ: MMAT) dropped 24.6% to $1.3799. Meta Materials recently announced FINRA has processed and announced the corporate action of exchanging META's Series A Preferred shares for shares of common stock of Next Bridge Hydrocarbons on its daily list.
  • My Size, Inc. (NASDAQ: MYSZ) fell 24% to $3.61.
  • Winc, Inc. (NYSE: WBEV) dropped 19% to $0.17.
  • Erasca, Inc. (NASDAQ: ERAS) fell 17.6% to $6.03 after the company priced a 15,384,616 share offering at $6.50 per share.
  • BioVie Inc. (NASDAQ: BIVI) dropped 16.9% to $7.56.
  • Flora Growth Corp. (NASDAQ: FLGC) fell 16.8% to $0.37 after the company announced pricing of a $5 million registered direct offering.
  • Sunlands Technology Group (NYSE: STG) declined 16.4% to $6.18.
  • Rent the Runway, Inc. (NASDAQ: RENT) fell 15% to $2.0150. Rent The Runway shares jumped 74% on Thursday after the company reported better-than-expected Q3 sales results.
  • Bluejay Diagnostics, Inc. (NASDAQ: BJDX) declined 15% to $0.45.
  • Save Foods, Inc. (NASDAQ: SVFD) dipped 14.3% to $0.8999.
  • Pharvaris N.V. (NASDAQ: PHVS) shares fell 14.2% to $9.83. Pharvaris shares jumped 339% on Thursday after the company reported top-line Phase 2 data from the RAPIDe-1 study of PHVS416 for the on-demand treatment of HAE attacks.
  • SHF Holdings, Inc. (NASDAQ: SHFS) dropped 13.6% to $3.4995.
  • Sono Group N.V. (NASDAQ: SEV) fell 13.2% to $0.9632. Sono Group shares dropped 5% on Thursday after the company reported worse-than-expected Q3 EPS results.
  • Torrid Holdings Inc. (NYSE: CURV) declined 13.1% to $3.7099 after the company reported worse-than-expected Q3 EPS and sales results and issued Q4 2022 and FY22 revenue guidance below estimates.
  • Tivic Health Systems, Inc. (NASDAQ: TIVC) dropped 12.3% to $0.9550. Tivic Health and Reliefband Technologies, LLC terminated acquisition agreement.
  • Lululemon Athletica (NASDAQ:LULU) Inc. (NASDAQ: LULU) fell 12.3% to $328.35. Lululemon posted upbeat results for its third quarter, but issued weak holiday-quarter guidance.
  • Party City Holdco Inc. (NYSE: PRTY) fell 12.1% to $0.5210.
  • TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares fell 11.3% to $0.6441after declining over 25% on Thursday. TransCode Therapeutics recently announced withdrawal of the Registration Statement on Form S-1 filed on November 28, 2022 for a share offering for up to 12.5 million.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Bitcoin

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.